Of note, mutations in IDH1 and IDH2 genes were shown to reprogram the metabolism of cancer cells to produce the onco-metabolite D-2-hydroxyglutarate and cells with mutations might be additionally dependent on lactate (see for review [75]). This evidence concerns the gene IDH2 and cancer.